Its initial identification in the context of a viral oncogene immediately implicated the PI3K pathway in cancer, and we now know that the genes encoding the p110α catalytic PI3K subunit and its negative regulator, phosphatase and tensin homolog (PTEN), are among the most commonly mutated in solid tumors. This evidence concerns the gene PIK3CB and cancer.